Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)

NCT07284641 is registered in ClinicalTrials.gov with Paul Szabolcs as lead sponsor.

NCT NCT07284641
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07284641 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)
Lead sponsor
Paul Szabolcs
Phase
Phase 2
Overall status
Recruiting
Start date
May 4, 2026
Completion date
February 1, 2031
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cd40 deficiency, cd40 ligand deficiency, chronic granulomatous disease, common variable immunodeficiency (cvid), digeorge syndrome, gata2 associated immunodeficiency, hypomorphic rag1 deficiency, hypomorphic rag2 deficiency, immune dysregulation, immune dysregulation polyendocrinopathy enteropathy x-linked syndrome, mendelian susceptibility to mycobacterial disease, omenn syndrome, primary immune regulatory disorder, stat 1 gain of function, stat 3 gain of function